...
首页> 外文期刊>Neuroendocrinology: International Journal for Basic and Clinical Studies on Neuroendocrine Relationships >Role of corticotropin-releasing hormone in gastrin-releasing peptide-mediated regulation of corticotropin and corticosterone secretion in male rats.
【24h】

Role of corticotropin-releasing hormone in gastrin-releasing peptide-mediated regulation of corticotropin and corticosterone secretion in male rats.

机译:促肾上腺皮质激素释放激素在胃泌素释放肽介导的雄性大鼠促肾上腺皮质激素和皮质酮分泌调节中的作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Gastrin-releasing peptide (GRP) exerts several functions within the hypothalamus and may be involved in the regulation of pituitary hormone secretion. The purpose of this study was to investigate the central effect of GRP on hypothalamic-pituitary-adrenal axis activity in the male rat. Intracerebroventricular (i.c.v.) but not intravenous administration of GRP (1, 10, 100 ng/rat) increased plasma ACTH and corticosterone concentrations in a dose-dependent manner. The highest dose (100 ng/rat) of GRP increased plasma ACTH and corticosterone 4- and 14-fold, respectively. This increase peaked at 30-60 min after i.c.v. injection, decreased gradually and returned to baseline levels 240 min after GRP administration. The i. c.v. administration of (Leu13-psi-CH2NH-Leu14) bombesin, a competitive and specific GRP receptor antagonist, had no effect on ACTH and corticosterone secretion; however, a dose of 1 microg/rat completely blocked the increase of both hormones induced by GRP (10 ng). By using alpha-helical (9-41) corticotropin-releasing factor (CRF), a competitive antagonist of CRF, the role of CRF on GRP-induced ACTH and corticosterone secretion was also explored. alpha-Helical (9-41) CRF (10 microg/rat) blocked the increase in ACTH and corticosterone secretion induced by GRP (10 ng). The results obtained in this study suggest that GRP increases the secretion of ACTH and corticosterone in the plasma by acting centrally on GRP receptors, and that endogenous GRP receptor ligands do not tonically regulate ACTH and corticosterone secretion. Furthermore, the hypothalamus-pituitary-adrenal-activating effects induced by GRP appear to be mediated, at least in part, by CRF.
机译:胃泌素释放肽(GRP)在下丘脑内发挥多种功能,并可能参与垂体激素分泌的调节。本研究的目的是研究GRP对雄性大鼠下丘脑-垂体-肾上腺轴活动的集中作用。脑室内(i.c.v.)但不静脉内给予GRP(1、10、100 ng /大鼠),血浆ACTH和皮质酮浓度呈剂量依赖性。 GRP的最高剂量(100 ng /大鼠)分别使血浆ACTH和皮质酮增加4倍和14倍。这种增加在静脉内麻醉后30-60分钟达到峰值。注射后,GRP给药后240分钟逐渐减少并回到基线水平。我简历。给予(Leu13-psi-CH2NH-Leu14)蛙心素,一种竞争性和特异性的GRP受体拮抗剂,对ACTH和皮质酮的分泌没有影响;但是,1微克/大鼠的剂量完全阻断了GRP(10 ng)诱导的两种激素的增加。通过使用α-螺旋(9-41)促肾上腺皮质激素释放因子(CRF),CRF的竞争性拮抗剂,还探讨了CRF在GRP诱导的ACTH和皮质酮分泌中的作用。 alpha-Helical(9-41)CRF(10 microg / rat)阻止了由GRP(10 ng)引起的ACTH和皮质酮分泌的增加。在这项研究中获得的结果表明,GRP通过集中作用于GRP受体来增加血浆中ACTH和皮质酮的分泌,并且内源性GRP受体配体不能调节性地调节ACTH和皮质酮的分泌。此外,由GRP诱导的下丘脑-垂体-肾上腺激活作用似乎至少部分地由CRF介导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号